Multivariate analysis of EFS, PFS, and OS adjusted for strata
| . | EFS HR (95% CI) . | P . | PFS HR (95% CI) . | P . | OS HR (95% CI) . | P . |
|---|---|---|---|---|---|---|
| Randomized patients | ||||||
| Allo-SCT vs auto-SCT | 0.9 (0.6-1.5) | .721 | 0.9 (0.5-1.5) | .702 | 1.3 (0.7-2.4) | .421 |
| LDH > NORMAL | 2.3 (1.3-4.1) | .004 | 2.4 (1.4-4.4) | .003 | 2.0 (1.0-4.3) | .064 |
| ECOG > 1 | 1.0 (0.5-1.8) | .901 | 1.0 (0.5-1.8) | .977 | 1.2 (0.6-2.5) | .648 |
| Stage III/IV | 1.0 (0.4-2.2) | .918 | 1.1 (0.5-2.6) | .844 | 1.4 (0.4-4.8) | .546 |
| E > 1 | 1.2 (0.7-2.1) | .492 | 1.2 (0.7-2.2) | .429 | 1.0 (0.5-1.9) | .896 |
| Transplant recipients | ||||||
| Allo-SCT vs auto-SCT* | 0.8 (0.3-1.7) | .513 | 0.8 (0.3-1.7) | .513 | 1.8 (0.7-4.6) | .218 |
| LDH > NORMAL | 1.4 (0.6-3.1) | .455 | 1.4 (0.6-3.1) | .455 | 1.0 (0.3-3.0) | .977 |
| ECOG > 1 | 1.1 (0.4-2.8) | .886 | 1.1 (0.4-2.8) | .886 | 2.3 (0.8-7.0) | .140 |
| Stage III/IV | 1.3 (0.4-4.5) | .645 | 1.3 (0.4-4.5) | .645 | 1.2 (0.3-5.4) | .807 |
| E > 1 | 0.6 (0.2-1.7) | .341 | 0.6 (0.2-1.7) | .341 | 0.5 (0.1-1.8) | .273 |
| . | EFS HR (95% CI) . | P . | PFS HR (95% CI) . | P . | OS HR (95% CI) . | P . |
|---|---|---|---|---|---|---|
| Randomized patients | ||||||
| Allo-SCT vs auto-SCT | 0.9 (0.6-1.5) | .721 | 0.9 (0.5-1.5) | .702 | 1.3 (0.7-2.4) | .421 |
| LDH > NORMAL | 2.3 (1.3-4.1) | .004 | 2.4 (1.4-4.4) | .003 | 2.0 (1.0-4.3) | .064 |
| ECOG > 1 | 1.0 (0.5-1.8) | .901 | 1.0 (0.5-1.8) | .977 | 1.2 (0.6-2.5) | .648 |
| Stage III/IV | 1.0 (0.4-2.2) | .918 | 1.1 (0.5-2.6) | .844 | 1.4 (0.4-4.8) | .546 |
| E > 1 | 1.2 (0.7-2.1) | .492 | 1.2 (0.7-2.2) | .429 | 1.0 (0.5-1.9) | .896 |
| Transplant recipients | ||||||
| Allo-SCT vs auto-SCT* | 0.8 (0.3-1.7) | .513 | 0.8 (0.3-1.7) | .513 | 1.8 (0.7-4.6) | .218 |
| LDH > NORMAL | 1.4 (0.6-3.1) | .455 | 1.4 (0.6-3.1) | .455 | 1.0 (0.3-3.0) | .977 |
| ECOG > 1 | 1.1 (0.4-2.8) | .886 | 1.1 (0.4-2.8) | .886 | 2.3 (0.8-7.0) | .140 |
| Stage III/IV | 1.3 (0.4-4.5) | .645 | 1.3 (0.4-4.5) | .645 | 1.2 (0.3-5.4) | .807 |
| E > 1 | 0.6 (0.2-1.7) | .341 | 0.6 (0.2-1.7) | .341 | 0.5 (0.1-1.8) | .273 |
Seven patients randomized to allo-SCT are included.